Abbott Introduces Molecular Diagnostic System Intended for Broad Identification of Infectious Agents CHICAGO, July 21 — Abbott (NYSE: ABT) today unveiled its new PLEX-ID system currently in development for detecting and characterizing a wide range of pathogens, including infectious agents commonly transmitted in hospitals and other clinical sites. PLEX-ID is the next generation of Abbott’s […]
SAFC Supply Solutions(R) Announces Raw Materials Line Developed Specifically to Meet Molecular Diagnostics Manufacturing Requirements ST. LOUIS, July 21 — SAFC Supply Solutions, a business segment of SAFC® (www.safcglobal.com), a member of the Sigma-Aldrich® Group (Nasdaq: SIAL – News), today announced the launch of a diverse product offer (www.safcsupplysolutions.com/molecular) designed to meet the demands of […]
Agilent Technologies Inc. (NYSE: A) today announced the availability of the HYCOR Ultra-Sensitive EIA System for allergen-specific IgE. The HYCOR Ultra-Sensitive EIA System is FDA-cleared for quantitative determination of specific IgE. Using a unique assay design, the system provides quantitative specific IgE detection with testing capacity sized for moderate to higher-volume labs. Based on proven […]
HALIFAX, July 21 /CNW/ – MedMira Inc., (“MedMira”) (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today that VWR International, LLC (VWR) has joined the Company’s Canadian distribution network. Headquartered in West Chester, Pennsylvania, VWR is a global laboratory supply and distribution company with worldwide sales in […]
Seegene’s Seeplex® RV Multiplex PCR Tests Prove Effective for the Identification of the New Influenza A H1N1 Plans on Track for Releasing a Dedicated Multiplex PCR Flu A Sub-Typing Test in Upcoming Flu Season ROCKVILLE, MD–(July 20, 2009) – Building on its widely distributed multiplex PCR technology platform, Seegene is now providing healthcare systems worldwide […]
Both companies to use Scorpions® technology for diagnostic products based on DNA methylation Press Release, Manchester, UK, and Berlin, Germany July 20, 2009 – DxS Ltd. (Manchester, UK) and Epigenomics AG (Frankfurt, Prime Standard: ECX) today announced that they have cross-licensed certain technologies enabling both companies to develop and commercialise in vitro diagnostic (IVD) products […]
TwistDx Launches World’s First DNA Amplification Kit Based on Recombinase Polymerase Amplification (RPA) – Products Based on RPA Technology Offers Alternative to PCR CAMBRIDGE, England–TwistDx, a developer of point-of-use nucleic acid diagnostics, announced today the launch of its TwistAmpTM product range, the world’s first DNA amplification products based on Recombinase Polymerase Amplification (RPA). Concurrently, TwistDx […]
Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc. PORTON DOWN, England, July 16 — Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed two patent license agreements with Roche Molecular Systems, Inc. (RMS). The licenses signed on 15 July 2009, provide Enigma full access […]
Luminex Receives FDA Clearance for an Update to the xTAG® Respiratory Viral Panel Package Insert Package Insert to Include Data from Two New Publications on 2009 Influenza A/H1N1 AUSTIN, Texas–Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared labeling updates for the […]
Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection Xpert C. difficile Test Establishes New Benchmarks for Speed and Accuracy, Addressing Major Deficiencies In Previously Available Tests SUNNYVALE, Calif., July 13 — Cepheid (Nasdaq: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
